Restless Legs Syndrome (RLS)
Medical Rationale
Peripheral neuropathy produces restless legs syndrome through sensory deafferentation that disrupts normal spinal cord inhibitory circuits. The loss of large-fiber afferent input from damaged peripheral nerves disinhibits spinal interneurons, producing the uncomfortable crawling, tingling, and pulling sensations that characterize RLS. Additionally, small-fiber neuropathy (which preferentially affects the legs) reduces dopaminergic signaling in the A11 hypothalamic-spinal pathway that normally suppresses involuntary leg movements during rest. EMG studies demonstrate that RLS patients with neuropathy have increased periodic limb movements in sleep (PLMS index >15/hour) compared to RLS without neuropathy. Studies show RLS prevalence of 25-40% in peripheral neuropathy patients versus 5-10% in the general population.
Key Studies
Gemignani F et al. (2006) J Neurol Neurosurg Psychiatry (neuropathy and RLS); Polydefkis M et al. (2000) Neurology (small-fiber neuropathy and RLS); Hattan E et al. (2009) J Clin Sleep Med (neuropathy-associated RLS).
Filing Tips
Sleep study documenting elevated PLMS index. Neurology evaluation diagnosing RLS with onset after peripheral neuropathy diagnosis. Document RLS symptoms (evening/nighttime leg discomfort relieved by movement) and sleep disruption. Neurology nexus letter connecting sensory deafferentation from neuropathy to RLS pathophysiology. There is no diagnostic code for RLS in 38 CFR Part 4. VA's adjudication manual (M21-1, Part V, Subpart iii, 12.A.2.j) tells raters to evaluate it under the peripheral nerve diagnostic code or codes in 38 CFR 4.124a that most closely match where in the legs the symptoms are felt, and some Board of Veterans' Appeals decisions have instead rated it by analogy to convulsive tic. Which code VA uses is a rating decision, so document exactly where in each leg the symptoms occur and when. (capture cfr-4.124a)
